The University of Chicago Header Logo

Connection

Alexis Demonbreun to Humans

Back to Details
This is a "connection" page, showing publications Alexis Demonbreun has written about Humans.
Alexis Demonbreun
Connection Strength
0.313
Humans
  1. mRNA intramuscular vaccination produces a robust IgG antibody response in advanced neuromuscular disease. Neuromuscul Disord. 2022 01; 32(1):33-35.
    View in: PubMed
    Score: 0.026
  2. Anti-latent TGFß binding protein 4 antibody improves muscle function and reduces muscle fibrosis in muscular dystrophy. Sci Transl Med. 2021 Sep 08; 13(610):eabf0376.
    View in: PubMed
    Score: 0.025
  3. COVID-19 mRNA Vaccination Generates Greater Immunoglobulin G Levels in Women Compared to Men. J Infect Dis. 2021 09 01; 224(5):793-797.
    View in: PubMed
    Score: 0.025
  4. Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure. JCI Insight. 2021 05 10; 6(9).
    View in: PubMed
    Score: 0.025
  5. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay. PLoS One. 2020; 15(8):e0237833.
    View in: PubMed
    Score: 0.024
  6. Muscle cell communication in development and repair. Curr Opin Pharmacol. 2017 06; 34:7-14.
    View in: PubMed
    Score: 0.019
  7. Plasma Membrane Repair in Health and Disease. Curr Top Membr. 2016; 77:67-96.
    View in: PubMed
    Score: 0.017
  8. Membrane fusion in muscle development and repair. Semin Cell Dev Biol. 2015 Sep; 45:48-56.
    View in: PubMed
    Score: 0.017
  9. Dynamin 2 the rescue for centronuclear myopathy. J Clin Invest. 2014 Mar; 124(3):976-8.
    View in: PubMed
    Score: 0.015
  10. Serum protein and imaging biomarkers after intermittent steroid treatment in muscular dystrophy. Sci Rep. 2024 11 20; 14(1):28745.
    View in: PubMed
    Score: 0.008
  11. Simultaneous electromechanical monitoring in engineered heart tissues using a mesoscale framework. Sci Adv. 2024 Sep 13; 10(37):eado7089.
    View in: PubMed
    Score: 0.008
  12. Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias. J Am Heart Assoc. 2024 May 21; 13(10):e030467.
    View in: PubMed
    Score: 0.008
  13. Susceptibility to innate immune activation in genetically mediated myocarditis. J Clin Invest. 2024 May 16; 134(13).
    View in: PubMed
    Score: 0.008
  14. Physiological stress improves stem cell modeling of dystrophic cardiomyopathy. Dis Model Mech. 2024 Jun 01; 17(6).
    View in: PubMed
    Score: 0.008
  15. Extracellular matrix contribution to disease progression and dysfunction in myopathy. Am J Physiol Cell Physiol. 2023 11 01; 325(5):C1244-C1251.
    View in: PubMed
    Score: 0.007
  16. Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients. Clin Immunol. 2023 07; 252:109634.
    View in: PubMed
    Score: 0.007
  17. No difference in anti-spike antibody and surrogate viral neutralization following SARS-CoV-2 booster vaccination in persons with HIV compared to controls (CO-HIV Study). Front Immunol. 2022; 13:1048776.
    View in: PubMed
    Score: 0.007
  18. COVID-19 symptom severity predicts neutralizing antibody activity in a community-based serological study. Sci Rep. 2022 07 18; 12(1):12269.
    View in: PubMed
    Score: 0.007
  19. Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2. Nat Commun. 2022 01 20; 13(1):405.
    View in: PubMed
    Score: 0.007
  20. Geographic disparities in COVID-19 case rates are not reflected in seropositivity rates using a neighborhood survey in Chicago. Ann Epidemiol. 2022 02; 66:44-51.
    View in: PubMed
    Score: 0.006
  21. Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history. Sci Rep. 2021 08 30; 11(1):17325.
    View in: PubMed
    Score: 0.006
  22. A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples. Sci Rep. 2021 07 28; 11(1):15321.
    View in: PubMed
    Score: 0.006
  23. Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming. JCI Insight. 2019 12 19; 4(24).
    View in: PubMed
    Score: 0.006
  24. Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes. JCI Insight. 2019 03 21; 4(6).
    View in: PubMed
    Score: 0.005
  25. Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers. JCI Insight. 2018 05 03; 3(9).
    View in: PubMed
    Score: 0.005
  26. Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping. J Clin Invest. 2015 Nov 02; 125(11):4186-95.
    View in: PubMed
    Score: 0.004
  27. Ferlin proteins in myoblast fusion and muscle growth. Curr Top Dev Biol. 2011; 96:203-30.
    View in: PubMed
    Score: 0.003
  28. The endocytic recycling protein EHD2 interacts with myoferlin to regulate myoblast fusion. J Biol Chem. 2008 Jul 18; 283(29):20252-60.
    View in: PubMed
    Score: 0.003
  29. Genetic background influences muscular dystrophy. Neuromuscul Disord. 2005 Oct; 15(9-10):601-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.